| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6003455 | Thrombosis Research | 2012 | 7 Pages |
Abstract
This study offers a unique perspective on 'real-world' thromboprophylaxis patterns and associated outcomes in THR and TKR patients in the US. It suggests that only 40% of THR/TKR patients receive ACCP-recommended thromboprophylaxis and that not receiving ACCP thromboprophylaxis is an independent risk factor for both DVT and PE.
Keywords
retrospective database analysisVTE prophylaxisACCPVTELMWHVKATHRTKRHIPAAPulmonary embolismvitamin K antagonistClinical ModificationVenous thromboembolismDeep vein thrombosisDVTTotal hip replacementTotal knee replacementBleedingICDInternational Classification of Diseasesconfidence intervalHealth Insurance Portability and Accountability Actodds ratiolow-molecular-weight heparinAmerican College of Chest Physicians
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Rita Selby, Bijan J. Borah, Heather P. McDonald, Henry J. Henk, Mark Crowther, Philip S. Wells,